Silver Spike Acquisition Corp. II (SPKB) to Postpone Extension Vote
by Nicholas Alan Clayton on 2023-03-06 at 7:08am

Silver Spike II (NASDAQ:SPKB) announced in an 8-K this morning that it intends to adjourn its special meeting set to be held at noon ET today and postpone it until the same time March 10 without conducting any business.

The extra days will give Silver Spike II’s sponsor to engage with its investors and possibly come to non-redemption agreements which have become increasingly common in this season of votes. Investors do not currently have a business combination to mull over, however.

Silver Spike II announced a merger with pharmaceutical firm Eleusis last January, but later terminated it in June.

As a part of the breakup fee, the SPAC is to receive an amount of shares equal to 3% of Eleusis’ total equity at the firm’s next capital raise, liquidity event or sale of the company. Should this occur after Silver Spike II has consummated a different business combination or liquidated, then these shares will be placed in escrow with a third-party payment agent.

The team’s deadline for consummating a new deal is up on March 15, but its extension proposal on the ballot would allow it to automatically extend one month at a time up to nine times. The team closed its first deal in 2021 with WM Holding, an ecommerce platform connecting consumers with local cannabis products.

 

Recent Posts
by Nicholas Alan Clayton on 2024-07-23 at 4:33pm

Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...

by Nicholas Alan Clayton on 2024-07-23 at 1:00pm

Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...

by Nicholas Alan Clayton on 2024-07-23 at 8:38am

At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...

by Nicholas Alan Clayton on 2024-07-22 at 12:22pm

Maquia Capital (NASDAQ:MAQC) has entered into a definitive agreement to combine with AI infrastructure firm Velocium at a valuation of $445 million. Miami-based Velocium is developing data center processors designed to be particularly efficient for use by AI applications and Web 3.0. The combined company is expected to trade on the Nasdaq under the symbol...

by Nicholas Alan Clayton on 2024-07-22 at 8:24am

At the SPAC of Dawn The third week of July brings just three votes and only ARYA IV‘s (NASDAQ:ARYD) is to complete a transaction, but plenty more is turning in SPACland. For one, this week’s anticipated IPO for M3-Brigade V (NASDAQ:MBAV) now looks notably different with 1/2 warrants in its units and its trust overfunded...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved